Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up
SourceAnnals of Oncology, 30, 6, (2019), pp. 970-976
Article / Letter to editor
Display more detailsDisplay less details
Annals of Oncology
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.